Substance / Medication

Cortisone acetate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

255 trials linked to this intervention

255
Total Trials
60
Recruiting
84
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis.
Singh Mangal, Niranjan H S, Mehrotra Ravi et al. · Indian J Med Res · 2010
PMID: 20516538RCT
Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis.
Kim Dong-Min, Chung Jong Hoon, Yoon Sung Ho et al. · Nephrol Dial Transplant · 2007
PMID: 17616536RCT
Topical treatment of acute otitis externa: clinical comparison of an antibiotics ointment alone or in combination with hydrocortisone acetate.
Mösges Ralph, Domröse Christian M, Löffler Jürgen · Eur Arch Otorhinolaryngol · 2007
PMID: 17503066RCT
Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F, Erkoçoğlu M, Tezer H et al. · Eur Rev Med Pharmacol Sci · 2012
PMID: 23242727Observational
[Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Leite Flavia M, Longui Carlos A, Kochi Cristiane et al. · Arq Bras Endocrinol Metabol · 2008
PMID: 18345402Observational
Posterior subcapsular cataract in association with fludrocortisone acetate therapy.
Whyte Ian M, Prior Felicity H, Emslie Ian K et al. · Clin Exp Ophthalmol · 2014
PMID: 24641708Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cortisone acetate (substance)
SNOMED CT
127382005
UMLS CUI
C0056391

Clinical Data

This intervention maps to 30 entities in the Healos knowledge graph.

20
Conditions
4
Biomarkers
4
Specialists
0
Symptoms
255
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.